Copilot
Din daglige ledsager med kunstig intelligens
Circa 107.000 resultater
  1. Ogivri
    https://www.ogivri.com

    OGIVRI® (trastuzumab-dkst)

    Udforsk videre

    What is the difference between Ogivri and Herceptin? - …
    drugs.com
    Recent Approval of Trastuzumab Biosimilar, Ogivri, Has …
    ajmc.com
    The 5 Trastuzumab Biosimilars: Full List, Info, and Savings - …
    goodrx.com
    Ogivri Injection: Package Insert - Drugs.com
    drugs.com
    FDA approves Ogivri as a biosimilar to Herceptin | FDA
    fda.gov
    Anbefalet til dig baseret på, hvad der er populært • Feedback
  2. Folk spørger også om
    What is ogivri (trastuzumab-DKST)?
    The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

    FDA approves first biosimilar for the treatment of certain breast and sto…

    fda.gov
    Is ogivri a biosimilar to Herceptin?
    On December 1, 2017, the Food and Drug Administration approved Ogivri (trastuzumab-dkst, Mylan) as a biosimilar to Herceptin (trastuzumab, Genentech, Inc.) for the treatment of patients with HER2-overexpressing breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma).

    FDA approves Ogivri as a biosimilar to Herceptin | FDA

    fda.gov
    Is ogivri a biosimilar?
    Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer and the second biosimilar approved in the U.S. for the treatment of cancer. As with any treatment, health care professionals should review the prescribing information in the labeling for detailed information about the approved uses.

    FDA approves first biosimilar for the treatment of certain breast and sto…

    fda.gov
    Is trastuzumab DKST a single dose?
    Single doses higher than 8 mg/kg have not been tested. Trastuzumab-dkst is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2 ...

    OGIVRI- trastuzumab-dkst kit OGIVRI- trastuzumab-dkst injection, pow…

    dailymed.nlm.nih.gov
    Feedback
  3. europa.eu
    https://www.ema.europa.eu/da/documents/product-informat… · PDF-fil

    Ogivri, INN - Trastuzumab

  4. ogivrihcp.com
    https://www.ogivrihcp.com

    OGIVRI® (trastuzumab-dkst) – FDA approved Viatris biosimilar

  5. Billeder af Ogivri trastuzumab Dk St

    bing.com/images
    Se alle billeder
  6. Food and Drug Administration (.gov)
    https://www.fda.gov/news-events/press-announcements/fda-approve…

    FDA approves first biosimilar for the treatment of certain breast …

  7. europa.eu
    https://www.ema.europa.eu/en/medicines/human/EPAR/ogivri

    Ogivri - European Medicines Agency

  8. Biocon
    https://www.biocon.com/biocon-and-mylan-launch-trastuzumab-bios…

    Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri™ …

  9. DailyMed
    https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b7938e6%20%E2%80%A6

    DailyMed - OGIVRI- trastuzumab-dkst kit OGIVRI- trastuzumab …

  10. Food and Drug Administration (.gov)
    https://www.fda.gov/.../fda-approves-ogivri-biosimilar-herceptin

    FDA approves Ogivri as a biosimilar to Herceptin | FDA

  11. OptumRx
    https://professionals.optumrx.com/.../drugapprovals_ogivri… · PDF-fil

    OgivriTM (trastuzumab-dkst) – New biosimilar approval

  12. Drugs.com
    https://www.drugs.com/cons/ogivri-trastuzumab-dkst-intravenous.h…

    Ogivri (Trastuzumab-dkst Intravenous) Advanced Patient …